JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2007; 49:1362-1368, doi:10.1016/j.jacc.2007.02.027 (Published online 8 March 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.02.027v1
49/12/1362    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (27)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manoukian, S. V.
Right arrow Articles by Stone, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manoukian, S. V.
Right arrow Articles by Stone, G. W.

EXPEDITED REVIEW

Impact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients With Acute Coronary Syndromes

An Analysis From the ACUITY Trial

Steven V. Manoukian, MD, FACC*,*, Frederick Feit, MD, FACC{dagger}, Roxana Mehran, MD, FACC{ddagger}, Michele D. Voeltz, MD*, Ramin Ebrahimi, MD, FACC§, Martial Hamon, MD||, George D. Dangas, MD, PhD, FACC{ddagger}, A. Michael Lincoff, MD, FACC, Harvey D. White, DSc, FACC#, Jeffrey W. Moses, MD, FACC{ddagger}, Spencer B. King, III, MD, MACC**, E. Magnus Ohman, MD, FACC{dagger}{dagger} and Gregg W. Stone, MD, FACC{ddagger}

* Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
** Fuqua Heart Center, Atlanta, Georgia
{dagger} Department of Medicine, New York University School of Medicine, New York, New York
{ddagger} Department of Medicine, Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York
§ Department of Medicine, University of California Los Angeles, Los Angeles, California
|| Service des Maladies du Coeur et des Vaisseaux, Centre Hospitalier Universitaire de Caen, Caen, France
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio
# Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand
{dagger}{dagger} Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

Manuscript received February 10, 2007; revised manuscript received February 26, 2007, accepted February 26, 2007.

* Reprint requests and correspondence: Dr. Steven V. Manoukian, Emory University School of Medicine, Emory Crawford Long Hospital, 550 Peachtree Street, MOT, 6th Floor, Cardiology, Atlanta, Georgia 30308. (Email: steven.manoukian{at}emory.edu).

Objectives: The purpose of this study was to determine the predictors of major bleeding and the impact of major bleeding on outcomes, including mortality, in acute coronary syndromes (ACS).

Background: Whether major bleeding independently predicts mortality in patients with ACS undergoing an early invasive strategy is undefined.

Methods: Patients (n = 13,819) with moderate- and high-risk ACS were randomized to heparin (unfractionated or enoxaparin) plus glycoprotein IIb/IIIa inhibition (GPI), bivalirudin plus GPI, or bivalirudin monotherapy (plus provisional GPI). Logistic regression was used to determine predictors of 30-day major bleeding and mortality.

Results: Major bleeding rates in patients treated with heparin plus GPI were higher versus bivalirudin monotherapy (5.7% vs. 3.0%, p < 0.001) and similar versus bivalirudin plus GPI (5.7% vs. 5.3%, p = 0.38). Independent predictors of major bleeding were advanced age, female gender, diabetes, hypertension, renal insufficiency, anemia, no prior percutaneous coronary intervention, cardiac biomarker elevation, ST-segment deviation ≥1 mm, and treatment with heparin plus GPI versus bivalirudin monotherapy. Patients with major bleeding had higher 30-day rates of mortality (7.3% vs. 1.2%, p < 0.0001), composite ischemia (23.1% vs. 6.8%, p < 0.0001), and stent thrombosis (3.4% vs. 0.6%, p < 0.0001) versus those without major bleeding. Major bleeding was an independent predictor of 30-day mortality (odds ratio 7.55, 95% confidence interval 4.68 to 12.18, p < 0.0001).

Conclusions: Major bleeding is a powerful independent predictor of 30-day mortality in patients with ACS managed invasively. Several factors independently predict major bleeding, including treatment with heparin plus GPI compared with bivalirudin monotherapy. Knowledge of these findings might be useful to reduce bleeding risk and improve outcomes in ACS.

Abbreviations and Acronyms
  ACS = acute coronary syndromes
  CABG = coronary artery bypass graft surgery
  GRACE = Global Registry of Acute Coronary Events
  GPI = glycoprotein IIb/IIIa inhibitor/inhibition
  MI = myocardial infarction
  PCI = percutaneous coronary intervention




This article has been cited by other articles:


Home page
 Eur Heart JHome page
O. F. Bertrand, J. Arsenault, and R. Mongrain
Operator vs. patient radiation exposure in transradial and transfemoral coronary interventions
Eur. Heart J., September 4, 2008; (2008) ehn394v1.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. D. White, E. M. Ohman, A. M. Lincoff, M. E. Bertrand, A. Colombo, B. T. McLaurin, D. A. Cox, S. J. Pocock, J. A. Ware, S. V. Manoukian, et al.
Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial
J. Am. Coll. Cardiol., September 2, 2008; 52(10): 807 - 814.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Budaj, J. W. Eikelboom, S. R. Mehta, R. Afzal, S. Chrolavicius, J.-P. Bassand, K. A.A. Fox, L. Wallentin, R. J. G. Peters, C. B. Granger, et al.
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes
Eur. Heart J., August 18, 2008; (2008) ehn358v1.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
S. V. Rao, F.-S. Ou, T. Y. Wang, M. T. Roe, R. Brindis, J. S. Rumsfeld, and E. D. Peterson
Trends in the Prevalence and Outcomes of Radial and Femoral Approaches to Percutaneous Coronary Intervention: A Report From the National Cardiovascular Data Registry
J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 379 - 386.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
A J Chase, E B Fretz, W P Warburton, W P Klinke, R G Carere, D Pi, B Berry, and J D Hilton
Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg)
Heart, August 1, 2008; 94(8): 1019 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The year in interventional cardiology.
J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2355 - 2369.
[Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
R. J. Applegate, M. T. Sacrinty, M. A. Kutcher, F. R. Kahl, S. K. Gandhi, R. M. Santos, and W. C. Little
Trends in Vascular Complications After Diagnostic Cardiac Catheterization and Percutaneous Coronary Intervention Via the Femoral Artery, 1998 to 2007
J. Am. Coll. Cardiol. Intv., June 1, 2008; 1(3): 317 - 326.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. G. Ellis, M. Tendera, M. A. de Belder, A. J. van Boven, P. Widimsky, L. Janssens, H.R. Andersen, A. Betriu, S. Savonitto, J. Adamus, et al.
Facilitated PCI in Patients with ST-Elevation Myocardial Infarction
N. Engl. J. Med., May 22, 2008; 358(21): 2205 - 2217.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
G. W. Stone, B. Witzenbichler, G. Guagliumi, J. Z. Peruga, B. R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B. J. Gersh, S. J. Pocock, et al.
Bivalirudin during Primary PCI in Acute Myocardial Infarction
N. Engl. J. Med., May 22, 2008; 358(21): 2218 - 2230.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
D. A. Morrow
Antithrombotic Therapy to Support Primary PCI
N. Engl. J. Med., May 22, 2008; 358(21): 2280 - 2282.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. D. White, D. P. Chew, J. W. Hoekstra, C. D. Miller, C. V. Pollack Jr, F. Feit, A. M. Lincoff, M. Bertrand, S. Pocock, J. Ware, et al.
Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1734 - 1741.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
J.-P. Bassand
Bleeding and transfusion in acute coronary syndromes: a shift in the paradigm
Heart, May 1, 2008; 94(5): 661 - 666.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
F. Feit, S. V. Manoukian, R. Ebrahimi, C. V. Pollack, E. M. Ohman, M. J. Attubato, R. Mehran, and G. W. Stone
Safety and Efficacy of Bivalirudin Monotherapy in Patients With Diabetes Mellitus and Acute Coronary Syndromes: A Report From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial
J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1645 - 1652.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Ndrepepa, P. B. Berger, J. Mehilli, M. Seyfarth, F.-J. Neumann, A. Schomig, and A. Kastrati
Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions Appropriateness of Including Bleeding as a Component of a Quadruple End Point.
J. Am. Coll. Cardiol., February 19, 2008; 51(7): 690 - 697.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. L. Dauerman
Percutaneous Coronary Intervention Pharmacology From a Triangle to a Square.
J. Am. Coll. Cardiol., February 19, 2008; 51(7): 698 - 700.
[Full Text] [PDF]

Home page
 CirculationHome page
P. B. Berger and S. V. Manoukian
Bleeding Is Bad.... Isn't It?
Circulation, December 11, 2007; 116(24): 2776 - 2778.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. P. Giugliano and E. Braunwald
The Year in Non ST-Segment Elevation Acute Coronary Syndrome
J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1386 - 1395.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
E. M. Tuzcu, R. C. Starling, and J. D. Thomas
Highlights of the 56th Annual Scientific Session of the American College of Cardiology, March 24-27, 2007. ACC.07 and i2 Summit Highlights: A Conversation With the Experts.
J. Am. Coll. Cardiol., August 21, 2007; 50(8 Suppl): C2 - 31.
[Full Text] [PDF]


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2007 by the American College of Cardiology Foundation.